Log In
Print
BCIQ
Print
Print this Print this
 

AMYtect

  Manage Alerts
Collapse Summary General Information
Company DiaGenic ASA
DescriptionBlood-based Alzheimer's disease (AD) test
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPilot
Standard IndicationNeurology, Diagnostic
Indication DetailsDiagnose Alzheimer's disease (AD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today